Developer docs
API playgroundTry for free, no card

Search company profiles

Genecis

Full company profile

uuid0000xna

Namestring
Genecis
Legal namestring
Genecis Bioindustries Inc.
Websiteurl
genecis.co
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Genecis Bioindustries is a Toronto-based climate biotechnology company that converts organic waste into biodegradable polyhydroxyalkanoate (PHA) plastics using a proprietary recombinant bacteria fermentation platform. Founded in 2016 by CEO Luna Yu, the company operates a 240-litre pilot plant and is commissioning a 3,000-litre demo facility, with an architecture designed to integrate onto existing biogas plant infrastructure rather than rely on purpose-built facilities. Its PHA output is tunable for rigid and flexible applications and is positioned as a drop-in substitute for petroleum-based plastics that fully biodegrades in roughly 12 months across land and marine environments.

The company sells to enterprise customers in single-use plastics, packaging, automotive, textiles, and medical device end-markets through a B2B go-to-market combining direct enterprise sales, custom polymer formulation services, rapid product development collaborations, and co-branding partnerships. Named strategic relationships include StormFisher (biogas infrastructure integration for commercial-scale production in London, Ontario), Helian Polymers (PHA resin development for 3D printing and biomedical applications), Sodexo (food services), and Novo Nordisk (medical/health applications). Production scale-up is staged, with the technology validated by a third-party lab at 1,000L.

Genecis is venture-capital-backed, having raised a US$7 million Series A in August 2022 led by Khosla Ventures and BDC Capital's Cleantech Practice, plus a US$3 million Silicon Valley Bank credit facility, with a subsequent US$3.25 million exempt offering in early 2023. Reported commercial traction includes $6 million in closed deals against a $55 million LOI pipeline. Revenue is not publicly disclosed and the company remains at pilot scale with 15 employees, indicating a pre-commercial or early-commercial revenue profile at present.

Short descriptiontext

Genecis Bioindustries is a Toronto-based climate biotech company that uses proprietary recombinant bacteria fermentation to convert organic waste into biodegradable PHA bioplastics, serving enterprise customers in packaging, single-use plastics, automotive, textiles, and medical sectors through direct B2B sales and co-development partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersScarborough, Canada
HQ citystring
Scarborough
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioplastics manufacturing, polyhydroxyalkanoate (PHA), organic waste valorization, synthetic biology platform, compostable biopolymers
Industry6 codes
PRIMARYIMANAAAG
Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends)
SECONDARYEUAAAIAC
Bio-based Polymers & Bioplastics (e.g., PLA, PHA, bio-PE/PP/PET, PBS)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYIMAEAOAB
Biodegradable Packaging Materials (films, trays, foams)
SECONDARYEUAAAIAA
Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYIMANABAF
Bio-Based & Biodegradable Compounds (PLA/PHA/Starch Blends)
NAICS code1 code
  • Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing3252
SIC code1 code
  • Industrial Organic Chemicals2860
Product category
Biodegradable Bioplastics
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1PHA Bioplastics Sales
TypeOne Time License
Description

Genecis develops and sells biodegradable PHA plastics to manufacturers for use in packaging, textiles, automotive, medical and other applications. Products include custom polymer formulations and co-branded products.

genecis.co
2Polymer Development Services
TypeProfessional Services
Description

Custom polymer formulation services where Genecis works with partners to develop ideal polymer formulations for current or new product lines. Includes technical validation and product development.

genecis.co
3Rapid Product Development
TypeProfessional Services
Description

Collaborative product development services to help partners bring PHA-based products to market faster. Includes design, testing, and launch support.

genecis.co
4Co-Branding Partnership
TypeLicensing Royalties
Description

Long-term co-branding partnerships where Genecis provides PHA materials and technical expertise for partners to create and market sustainable products under joint branding.

genecis.co
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Operations, Personnel, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Genecis Bioindustries produces biodegradable polyhydroxyalkanoate (PHA) bioplastics by fermenting organic food waste using proprietary engineered bacteria. The company sells PHA bioplastic pellets and custom-formulated compounds to manufacturers in packaging, automotive, textile, and medical sectors, and offers polymer development and co-branding services for sustainable product lines.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • PHA biodegrades completely within 12 months in natural environments, compared to oil-based plastics that take up to 1000 years and leave microplastics
+3 more records
Product overview1 text field

Genecis is a climate biotech company offering a unified platform centered on PHA (Polyhydroxyalkanoate) bioplastics produced through proprietary bacterial fermentation of organic waste. The product portfolio includes four application-specific PHA formulations: Single-Use Plastics (replacement for packaging and bags), Automotive & Textiles (rigid and flexible formulations), Packaging (compostable solutions), and Medical Tools & Products (medical-grade implants and equipment). The service layer consists of three modules—Polymer Development (custom resin formulation), Rapid Product Development (6-month product validation and launch), and Co-Branding (market differentiation partnership)—enabling businesses to de-risk their transition to sustainable materials. The company also commercialized Folly, a hair health gummy brand leveraging proprietary microencapsulation technology derived from its parent company's biotech capabilities.

Product and service2 records
1PHA Bioplastics
CategoryBiodegradable bioplastics
Description

Fully biodegradable polyhydroxyalkanoate (PHA) bioplastic pellets and compounds produced from organic food waste via proprietary fermentation. Sold to manufacturers in packaging, automotive, textile, and medical sectors as a compostable alternative to petroleum-based plastics.

2Polymer Development Services
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-12-16
Description

Strategic collaboration to develop PHA-based resin formulations for high-value applications including 3D printing filaments and biomedical applications. Combines Genecis' waste-to-PHA capabilities with Helian's PHA material development expertise. Both companies will develop various formulations leveraging their respective strengths in bioplastics.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-08-04
Description

Biogas plant operator in London, Canada where Genecis will integrate its technology for the first commercial-scale production. This partnership enables Genecis to piggyback onto existing biogas infrastructure for rapid scaling.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Early corporate partner that shared Genecis' vision of sustainable production and waste reduction. One of the first major companies to work with Genecis.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Accepted Genecis into their Innovation Challenge program, recognizing the company's innovative approach to sustainability in the health and wellness sector.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Italian producer of Mater-Bi compostable bioplastics (starch/PBAT blends); established competitor in the same compostable-packaging end market that Genecis targets.

TypeDirect peer
Description

Publicly listed US-based PHA (Nodax) producer and direct competitor; targets same biodegradable packaging, foodservice, and consumer goods applications as Genecis.

TypeDirect peer
Description

Singapore/US PHA (Solon) producer using bacterial fermentation of plant oils; closest technology and product analog to Genecis's PHA platform.

TypeDirect peer
Description

Japanese chemical company producing Kaneka PHBH PHA biopolymers; competing directly with Genecis in packaging and single-use plastic replacement markets.

5TianAn Biopolymer
TypeDirect peer
Description

Chinese PHB/PHA polymer producer (Enmat) supplying biodegradable plastics for packaging and consumer goods; similar product portfolio to Genecis.

TypeEmerging player
Description

US startup producing PHA from methane/waste gases using engineered microbes; adjacent waste-to-PHA technology approach comparable to Genecis's waste-feedstock model.

TypeBroad incumbent
Description

South Korean conglomerate producing PHACT PHA biopolymers; much larger fermentation footprint than Genecis with established industrial customer base.

TypeBroad incumbent
Description

Producer of Ingeo PLA biopolymers; the largest commercial bioplastic incumbent and direct substitute for Genecis PHA in packaging applications.

TypeBroad incumbent
Description

Global chemical major producing Ecovio (PLA/PBAT blend); competitor and award-giver (BASF Innovation Pitch Series) targeting same single-use and compostable packaging market.

TypeEmerging player
Description

US company producing AirCarbon PHA from greenhouse gases; a direct microbial-PHA competitor at similar maturity to Genecis.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds11 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors29 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Genecis

Biodegradable Bioplasticsgenecis.co

Genecis Bioindustries is a Toronto-based climate biotech company that uses proprietary recombinant bacteria fermentation to convert organic waste into biodegradable PHA bioplastics, serving enterprise customers in packaging, single-use plastics, automotive, textiles, and medical sectors through direct B2B sales and co-development partnerships.

What Genecis does

Genecis Bioindustries is a Toronto-based climate biotechnology company that converts organic waste into biodegradable polyhydroxyalkanoate (PHA) plastics using a proprietary recombinant bacteria fermentation platform. Founded in 2016 by CEO Luna Yu, the company operates a 240-litre pilot plant and is commissioning a 3,000-litre demo facility, with an architecture designed to integrate onto existing biogas plant infrastructure rather than rely on purpose-built facilities. Its PHA output is tunable for rigid and flexible applications and is positioned as a drop-in substitute for petroleum-based plastics that fully biodegrades in roughly 12 months across land and marine environments.

The company sells to enterprise customers in single-use plastics, packaging, automotive, textiles, and medical device end-markets through a B2B go-to-market combining direct enterprise sales, custom polymer formulation services, rapid product development collaborations, and co-branding partnerships. Named strategic relationships include StormFisher (biogas infrastructure integration for commercial-scale production in London, Ontario), Helian Polymers (PHA resin development for 3D printing and biomedical applications), Sodexo (food services), and Novo Nordisk (medical/health applications). Production scale-up is staged, with the technology validated by a third-party lab at 1,000L.

Genecis is venture-capital-backed, having raised a US$7 million Series A in August 2022 led by Khosla Ventures and BDC Capital's Cleantech Practice, plus a US$3 million Silicon Valley Bank credit facility, with a subsequent US$3.25 million exempt offering in early 2023. Reported commercial traction includes $6 million in closed deals against a $55 million LOI pipeline. Revenue is not publicly disclosed and the company remains at pilot scale with 15 employees, indicating a pre-commercial or early-commercial revenue profile at present.

Genecis firmographics

Firmographics
Name
Genecis
Legal name
Genecis Bioindustries Inc.
Website
https://genecis.co
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Genecis Bioindustries is a Toronto-based climate biotech company that uses proprietary recombinant bacteria fermentation to convert organic waste into biodegradable PHA bioplastics, serving enterprise customers in packaging, single-use plastics, automotive, textiles, and medical sectors through direct B2B sales and co-development partnerships.
Ownership category
akta.pro rank

Genecis industry classification

Industry
Product category
Biodegradable Bioplastics
NAICS
Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing (3252)
SIC
Industrial Organic Chemicals (2860)
akta.pro industry
PRIMARYIMANAAAG
Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends)
SECONDARYEUAAAIAC
Bio-based Polymers & Bioplastics (e.g., PLA, PHA, bio-PE/PP/PET, PBS)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYIMAEAOAB
Biodegradable Packaging Materials (films, trays, foams)
SECONDARYEUAAAIAA
Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYIMANABAF
Bio-Based & Biodegradable Compounds (PLA/PHA/Starch Blends)

Keywords

  • Bioplastics manufacturing
  • Polyhydroxyalkanoate (PHA)
  • Organic waste valorization
  • Synthetic biology platform
  • Compostable biopolymers

Where Genecis is headquartered

Location

Headquarters

HQ city
Scarborough
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Genecis business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Operations, Personnel, Infrastructure

Revenue model

  1. PHA Bioplastics Sales: Genecis develops and sells biodegradable PHA plastics to manufacturers for use in packaging, textiles, automotive, medical and other applications. Products include custom polymer formulations and co-branded products.
  2. Polymer Development Services: Custom polymer formulation services where Genecis works with partners to develop ideal polymer formulations for current or new product lines. Includes technical validation and product development.
  3. Rapid Product Development: Collaborative product development services to help partners bring PHA-based products to market faster. Includes design, testing, and launch support.
  4. Co-Branding Partnership: Long-term co-branding partnerships where Genecis provides PHA materials and technical expertise for partners to create and market sustainable products under joint branding.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

Genecis product offering

Product offering

Core offering

Genecis Bioindustries produces biodegradable polyhydroxyalkanoate (PHA) bioplastics by fermenting organic food waste using proprietary engineered bacteria. The company sells PHA bioplastic pellets and custom-formulated compounds to manufacturers in packaging, automotive, textile, and medical sectors, and offers polymer development and co-branding services for sustainable product lines.

Product overview

Genecis is a climate biotech company offering a unified platform centered on PHA (Polyhydroxyalkanoate) bioplastics produced through proprietary bacterial fermentation of organic waste. The product portfolio includes four application-specific PHA formulations: Single-Use Plastics (replacement for packaging and bags), Automotive & Textiles (rigid and flexible formulations), Packaging (compostable solutions), and Medical Tools & Products (medical-grade implants and equipment). The service layer consists of three modules—Polymer Development (custom resin formulation), Rapid Product Development (6-month product validation and launch), and Co-Branding (market differentiation partnership)—enabling businesses to de-risk their transition to sustainable materials. The company also commercialized Folly, a hair health gummy brand leveraging proprietary microencapsulation technology derived from its parent company's biotech capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

  • PHA Bioplastics Fully biodegradable polyhydroxyalkanoate (PHA) bioplastic pellets and compounds produced from organic food waste via proprietary fermentation. Sold to manufacturers in packaging, automotive, textile, and medical sectors as a compostable alternative to petroleum-based plastics.
  • Polymer Development Services

Quantifiable outcome

  • PHA biodegrades completely within 12 months in natural environments, compared to oil-based plastics that take up to 1000 years and leave microplastics
  • +3 more outcomes

Companies that use Genecis

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Genecis technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Genecis partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and supporting.

  • Helian PolymerscoreStrategic or Co-development Partner · 16 December 2022Strategic collaboration to develop PHA-based resin formulations for high-value applications including 3D printing filaments and biomedical applications. Combines Genecis' waste-to-PHA capabilities with Helian's PHA material development expertise. Both companies will develop various formulations leveraging their respective strengths in bioplastics.
  • StormFishercoreStrategic or Co-development Partner · 4 August 2022Biogas plant operator in London, Canada where Genecis will integrate its technology for the first commercial-scale production. This partnership enables Genecis to piggyback onto existing biogas infrastructure for rapid scaling.
  • SodexosupportingStrategic or Co-development PartnerEarly corporate partner that shared Genecis' vision of sustainable production and waste reduction. One of the first major companies to work with Genecis.
  • Novo NordisksupportingStrategic or Co-development PartnerAccepted Genecis into their Innovation Challenge program, recognizing the company's innovative approach to sustainability in the health and wellness sector.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

Genecis competitors and assessment

Company assessment

Broad incumbents

  • Novamont: Italian producer of Mater-Bi compostable bioplastics (starch/PBAT blends); established competitor in the same compostable-packaging end market that Genecis targets.
  • CJ CheilJedang: South Korean conglomerate producing PHACT PHA biopolymers; much larger fermentation footprint than Genecis with established industrial customer base.
  • NatureWorks: Producer of Ingeo PLA biopolymers; the largest commercial bioplastic incumbent and direct substitute for Genecis PHA in packaging applications.
  • BASF: Global chemical major producing Ecovio (PLA/PBAT blend); competitor and award-giver (BASF Innovation Pitch Series) targeting same single-use and compostable packaging market.

Direct peers

  • Danimer Scientific: Publicly listed US-based PHA (Nodax) producer and direct competitor; targets same biodegradable packaging, foodservice, and consumer goods applications as Genecis.
  • RWDC Industries: Singapore/US PHA (Solon) producer using bacterial fermentation of plant oils; closest technology and product analog to Genecis's PHA platform.
  • Kaneka: Japanese chemical company producing Kaneka PHBH PHA biopolymers; competing directly with Genecis in packaging and single-use plastic replacement markets.
  • TianAn Biopolymer: Chinese PHB/PHA polymer producer (Enmat) supplying biodegradable plastics for packaging and consumer goods; similar product portfolio to Genecis.

Emerging players

  • Mango Materials: US startup producing PHA from methane/waste gases using engineered microbes; adjacent waste-to-PHA technology approach comparable to Genecis's waste-feedstock model.
  • Newlight Technologies: US company producing AirCarbon PHA from greenhouse gases; a direct microbial-PHA competitor at similar maturity to Genecis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Genecis social profiles

Digital presence

Genecis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Genecis leadership team

Management profile

Number of profiles

Profiles3 records

Genecis funding detail

Funding detail

Funding overview

Funding rounds11 records

Investors29 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Genecis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genecis

What does Genecis do?

Genecis Bioindustries produces biodegradable polyhydroxyalkanoate (PHA) bioplastics by fermenting organic food waste using proprietary engineered bacteria. The company sells PHA bioplastic pellets and custom-formulated compounds to manufacturers in packaging, automotive, textile, and medical sectors, and offers polymer development and co-branding services for sustainable product lines.

Is Genecis a public or private company?

Genecis is a private company. It is classified as venture growth investor backed and is currently operating.

When was Genecis founded?

Genecis was founded in 2016. It employs 11 to 50 people.

Where is Genecis based?

Genecis is headquartered in Scarborough, Canada, in the North America region.

How does Genecis make money?

Four revenue lines are on record. PHA Bioplastics Sales are the primary driver. The others are polymer Development Services, rapid Product Development and co-Branding Partnership.

Who are Genecis's main competitors?

Broad incumbents on record are Novamont, CJ CheilJedang, NatureWorks and BASF. Direct peers are Danimer Scientific, RWDC Industries, Kaneka and TianAn Biopolymer. Emerging players are Mango Materials and Newlight Technologies.

Does Genecis have an API?

No public API is recorded for Genecis.

What industry is Genecis in?

Genecis's product category is Biodegradable Bioplastics. Its primary akta.pro industry code is IMANAAAG, Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends), with a secondary code of EUAAAIAC, Bio-based Polymers & Bioplastics (e.g., PLA, PHA, bio-PE/PP/PET, PBS). Its NAICS code is 3252 and its SIC code is 2860.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
LinkedInGenecis launches Mad Coffee, a biodegradable coffee brandGenecis Bioindustries Inc. launched Mad Coffee, a consumer brand featuring instant cold-soluble coffee crystals packaged in industrially compostable pods made from biodegradable PHA plastic. The company plans to commercialize the concept with a major US supermarket starting in July and is offering contract manufacturing services for other brands. This launch follows the success of its predecessor product, Mad Tea, which generated over $1 million in sales within six months.foodnavigator-usa.comThe push for PHA: How Mad Tea’s compostable pods shift packaging standardsMad Tea, a biotech offshoot of Genecis Bioindustries, launched compostable Nespresso-compatible tea pods made from a PHA blend. The company aims to develop 100% PHA pods for home composting within one to two years, but scaling faces high costs and limited infrastructure. Vertical integration could cut production costs by 50%.The Globe and MailHow Canadian bioplastic innovations are replenishing the planetThree Canadian startups are developing compostable bioplastics: PhyCo Technologies uses seaweed, Genecis Bioindustries uses food waste, and a University of Western Ontario team uses hemp. Genecis raised $30 million and reported $5 million in revenue last year. The companies aim to replace petroleum-based plastics in agriculture and packaging.Alberta Beef ProducersFood waste solutions: Winners of Novel Technologies Stream announcedDuring Canadian Innovation Week 2024, the Minister of Agriculture and Agri-Food Canada, Lawrence MacAulay, announced the winners of the Novel Technologies Streams for the Food Reduction Challenge: Clean Works Inc. and Genecis Bioindustries Inc. Each company will receive a grand prize of up to $1 million to advance their solutions, which aim to reduce food waste significantly in Canada.GlobeNewswireBasetwo and Genecis Secure $4.3 Million Project to Revolutionize Life Science Manufacturing with AI-Enabled Digital TwinsBasetwo and Genecis secured $4.3 million from Next Generation Manufacturing Canada to develop AI-enabled digital twins of bioreactor systems. The project aims to optimize Genecis's process converting food waste into biodegradable plastics, with real-time prediction and scale-up capabilities.SecSEC FORM DGenecis Bioindustries Inc. filed a Form D with the SEC to report an exempt securities offering under Rule 506(b). The company raised a total of $3,250,002 from six investors in this equity offering.SecSEC FORM DThe Securities and Exchange Commission received a filing for an exempt offering of securities by Genecis Bioindustries Inc., which is a corporation based in Canada. The total offering amount is reported to be $1,500,000 USD, and the issuer intends for the offering to last no more than one year. This is a standard procedure for companies seeking to raise capital through securities offerings.BDC.caGenecis BioindustriesGenecis Bioindustries is a Canadian biotechnology company that develops microbial fermentation processes to upcycle waste into high-value materials like bioplastics. The company aims to reduce ocean plastic pollution by enabling major brands to utilize eco-friendly PHA plastics in various industries.NewsfileGenecis Raises US$10 Million in Funding to Commercialize Biodegradable Plastic ProductsGenecis Bioindustries Inc. announced the raising of US$7 million in Series A funding led by Khosla Ventures and BDC Capital, alongside a US$3 million credit facility from Silicon Valley Bank. The capital is intended to accelerate the commercialization of its biodegradable plastic products and complete the integration of its technology with a biogas plant in London, Canada. This investment supports Genecis' mission to upcycle food waste into sustainable PHA plastics for various industries.GlobeNewswireGenecis Receives Funding from NGen to Scale Sustainable Bioplastic Production from Organic WasteNGen announced $6 million in funding for Genecis Bioindustries to develop a biotechnology platform converting food waste into PHA bioplastics. The demonstration project will use StormFisher's anaerobic digestion plant in Drumbo, Ontario, producing resins for packaging, agricultural, medical, and additive manufacturing applications.